Patienter bør imidlertid være advarede om risikoen for hypoglycæmi, når metformin anvendes i kombination med andre antidiabetiske midler (sulfonylurinstoffer, insulin, repaglinid).
However, patients should be alerted to the risk of hypoglycaemia when metformin is used in combination with other antidiabetic agents (sulfonylureas, insulin, repaglinide).